AI
| Followers | 843 |
| Posts | 122806 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Thursday, April 05, 2007 3:14:44 PM
Re: Sculptra
The product seems to fit into a no-man’s land (actually a no-woman’s land, since the overwhelming majority of dermal-filler patients are female) between Restylane/Juvederm and ArteFill. I don’t think it will succeed in the cosmetic arena where patients have to pay their own way.
>Just finished my first Artecol injections… Eventually he agreed to let me inject the patient free of charge as a trial, but I'm leary at this point and don't see myself using it again.<
I hope you remembered to send in your malpractice premium
p.s. I assume you mean ArteFill rather than ArteColl. The latter is not being marketed in the U.S.
The product seems to fit into a no-man’s land (actually a no-woman’s land, since the overwhelming majority of dermal-filler patients are female) between Restylane/Juvederm and ArteFill. I don’t think it will succeed in the cosmetic arena where patients have to pay their own way.
>Just finished my first Artecol injections… Eventually he agreed to let me inject the patient free of charge as a trial, but I'm leary at this point and don't see myself using it again.<
I hope you remembered to send in your malpractice premium
p.s. I assume you mean ArteFill rather than ArteColl. The latter is not being marketed in the U.S.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
